Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Sep;116(2):1801–1808. doi: 10.1111/j.1476-5381.1995.tb16666.x

Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat.

F N Ko 1, S M Yu 1, Y F Kang 1, C M Teng 1
PMCID: PMC1909070  PMID: 8528563

Abstract

1. The effects of the thromboxane A2 (TxA2)-mimetic, U-46619, on the proliferation of vascular smooth muscle cells (VSMCs) were examined in a clonal smooth muscle cell line, A10, which was derived from foetal rat aorta. 2. [3H]-U-46619 bound to A10 cells of passages 18-20 (p18-20) with two classes of sites. The high affinity site showed a Bmax of 3.0 +/- 1.8 fmol mg-1 protein with a KD value 1.0 +/- 0.1 nM, while the low affinity site showed a Bmax of 43.0 +/- 6.0 fmol mg-1 protein and KD value of 129.0 +/- 7.9 nM. However, [3H]-U-46619 bound to A10 cells from passages 28-30 (p28-30) at a single class of site with a Bmax 111.0 +/- 9.0 fmol mg-1 protein and a KD value of 175.4 +/- 22.0 nM. 3. Cinnamophilin and SQ29548 inhibited specific [3H]-U-46619 binding to p18-20 A10 cells in a concentration-dependent manner with Ki values of 390.0 +/- 3.2 and 4.6 +/- 1.0 nM, respectively at a high affinity site, and 2.6 +/- 0.2 microM and 310.0 +/- 6.4 nM, respectively at the low affinity site. 4. U-46619 produced isometric contractions of rat aorta in a concentration-dependent manner with an EC50 7.0 +/- 1.2 nM. Cinnamophilin and SQ29548 antagonized U-46619-induced aortic contractions with pA2 values 6.3 +/- 0.1 and 8.2 +/- 0.2, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
1801

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alexander S. P., Kendall D. A., Hill S. J. Differences in the adenosine receptors modulating inositol phosphates and cyclic AMP accumulation in mammalian cerebral cortex. Br J Pharmacol. 1989 Dec;98(4):1241–1248. doi: 10.1111/j.1476-5381.1989.tb12670.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Berk B. C., Alexander R. W. Vasoactive effects of growth factors. Biochem Pharmacol. 1989 Jan 15;38(2):219–225. doi: 10.1016/0006-2952(89)90030-0. [DOI] [PubMed] [Google Scholar]
  3. Borg C., Lim C. T., Yeomans D. C., Dieter J. P., Komiotis D., Anderson E. G., Le Breton G. C. Purification of rat brain, rabbit aorta, and human platelet thromboxane A2/prostaglandin H2 receptors by immunoaffinity chromatography employing anti-peptide and anti-receptor antibodies. J Biol Chem. 1994 Feb 25;269(8):6109–6116. [PubMed] [Google Scholar]
  4. Campbell G. R., Campbell J. H. Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol. 1985 Apr;42(2):139–162. doi: 10.1016/0014-4800(85)90023-1. [DOI] [PubMed] [Google Scholar]
  5. Dorn G. W., 2nd, Becker M. W., Davis M. G. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle. J Biol Chem. 1992 Dec 5;267(34):24897–24905. [PubMed] [Google Scholar]
  6. Fukuo K., Morimoto S., Koh E., Yukawa S., Tsuchiya H., Imanaka S., Yamamoto H., Onishi T., Kumahara Y. Effects of prostaglandins on the cytosolic free calcium concentration in vascular smooth muscle cells. Biochem Biophys Res Commun. 1986 Apr 14;136(1):247–252. doi: 10.1016/0006-291x(86)90901-0. [DOI] [PubMed] [Google Scholar]
  7. Gryglewski R. J., Dembińska-Kiè A., Zmuda A., Gryglewska T. Prostacyclin and thromboxane A2 biosynthesis capacities of heart, arteries and platelets at various stages of experimental atherosclerosis in rabbits. Atherosclerosis. 1978 Dec;31(4):385–394. doi: 10.1016/0021-9150(78)90133-8. [DOI] [PubMed] [Google Scholar]
  8. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985 Mar 25;260(6):3440–3450. [PubMed] [Google Scholar]
  9. Hamberg M., Svensson J., Samuelsson B. Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A. 1975 Aug;72(8):2994–2998. doi: 10.1073/pnas.72.8.2994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hanasaki K., Arita H. A common binding site for primary prostanoids in vascular smooth muscles: a definitive discrimination of the binding for thromboxane A2/prostaglandin H2 receptor agonist from its antagonist. Biochim Biophys Acta. 1989 Sep 4;1013(1):28–35. doi: 10.1016/0167-4889(89)90123-7. [DOI] [PubMed] [Google Scholar]
  11. Hanasaki K., Nakano T., Arita H. Receptor-mediated mitogenic effect of thromboxane A2 in vascular smooth muscle cells. Biochem Pharmacol. 1990 Dec 1;40(11):2535–2542. doi: 10.1016/0006-2952(90)90096-4. [DOI] [PubMed] [Google Scholar]
  12. Ip J. H., Fuster V., Badimon L., Badimon J., Taubman M. B., Chesebro J. H. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol. 1990 Jun;15(7):1667–1687. doi: 10.1016/0735-1097(90)92845-s. [DOI] [PubMed] [Google Scholar]
  13. Ishimitsu T., Uehara Y., Ishii M., Ikeda T., Matsuoka H., Sugimoto T. Alterations of the cardiovascular and renal prostaglandins and thromboxanes system in prehypertensive spontaneously hypertensive rats. Jpn Circ J. 1989 Apr;53(4):307–312. doi: 10.1253/jcj.53.307. [DOI] [PubMed] [Google Scholar]
  14. Ishimitsu T., Uehara Y., Ishii M., Ikeda T., Matsuoka H., Sugimoto T. Thromboxane and vascular smooth muscle cell growth in genetically hypertensive rats. Hypertension. 1988 Jul;12(1):46–51. doi: 10.1161/01.hyp.12.1.46. [DOI] [PubMed] [Google Scholar]
  15. Ishimitsu T., Uehara Y., Ishii M., Matsukoa H., Ikeda T., Sugimoto T. Roles of endogenous vasodepressor prostaglandins in growth of vascular smooth muscle cells in spontaneously hypertensive rats. Jpn Circ J. 1990 Dec;54(12):1546–1553. doi: 10.1253/jcj.54.12_1546. [DOI] [PubMed] [Google Scholar]
  16. Kimes B. W., Brandt B. L. Characterization of two putative smooth muscle cell lines from rat thoracic aorta. Exp Cell Res. 1976 Mar 15;98(2):349–366. doi: 10.1016/0014-4827(76)90446-8. [DOI] [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. March K. L., Wilensky R. L., Roeske R. W., Hathaway D. R. Effects of thiol protease inhibitors on cell cycle and proliferation of vascular smooth muscle cells in culture. Circ Res. 1993 Feb;72(2):413–423. doi: 10.1161/01.res.72.2.413. [DOI] [PubMed] [Google Scholar]
  19. Masuda A., Mais D. E., Oatis J. E., Jr, Halushka P. V. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat. Biochem Pharmacol. 1991 Jul 15;42(3):537–544. doi: 10.1016/0006-2952(91)90316-w. [DOI] [PubMed] [Google Scholar]
  20. Morinelli T. A., Zhang L. M., Newman W. H., Meier K. E. Thromboxane A2/prostaglandin H2-stimulated mitogenesis of coronary artery smooth muscle cells involves activation of mitogen-activated protein kinase and S6 kinase. J Biol Chem. 1994 Feb 25;269(8):5693–5698. [PubMed] [Google Scholar]
  21. Munson P. J., Rodbard D. Ligand: a versatile computerized approach for characterization of ligand-binding systems. Anal Biochem. 1980 Sep 1;107(1):220–239. doi: 10.1016/0003-2697(80)90515-1. [DOI] [PubMed] [Google Scholar]
  22. Nagata T., Uehara Y., Numabe A., Ishimitsu T., Hirawa N., Ikeda T., Matsuoka H., Sugimoto T. Regulatory effect of thromboxane A2 on proliferation of vascular smooth muscle cells from rats. Am J Physiol. 1992 Nov;263(5 Pt 2):H1331–H1338. doi: 10.1152/ajpheart.1992.263.5.H1331. [DOI] [PubMed] [Google Scholar]
  23. Nakano T., Hanasaki K., Arita H. Different effects of two thromboxane A2/prostaglandin H2 receptor ligands, U46619 and S-145, on rabbit platelets. FEBS Lett. 1988 Jul 18;234(2):309–312. doi: 10.1016/0014-5793(88)80105-4. [DOI] [PubMed] [Google Scholar]
  24. Osborne J. A., Lefer A. M. Cardioprotective actions of thromboxane receptor antagonism in ischemic atherosclerotic rabbits. Am J Physiol. 1988 Aug;255(2 Pt 2):H318–H324. doi: 10.1152/ajpheart.1988.255.2.H318. [DOI] [PubMed] [Google Scholar]
  25. Pouysségur J., Seuwen K. Transmembrane receptors and intracellular pathways that control cell proliferation. Annu Rev Physiol. 1992;54:195–210. doi: 10.1146/annurev.ph.54.030192.001211. [DOI] [PubMed] [Google Scholar]
  26. Ross R. The pathogenesis of atherosclerosis--an update. N Engl J Med. 1986 Feb 20;314(8):488–500. doi: 10.1056/NEJM198602203140806. [DOI] [PubMed] [Google Scholar]
  27. Uehara Y., Ishimitsu T., Kimura K., Ishii M., Ikeda T., Sugimoto T. Regulatory effects of eicosanoids on thymidine uptake by vascular smooth muscle cells of rats. Prostaglandins. 1988 Dec;36(6):847–857. doi: 10.1016/0090-6980(88)90061-5. [DOI] [PubMed] [Google Scholar]
  28. Uehara Y., Tobian L., Iwai J., Ishii M., Sugimoto T. Alterations of vascular prostacyclin and thromboxane A2 in Dahl genetical strain susceptible to salt-induced hypertension. Prostaglandins. 1987 May;33(5):727–738. doi: 10.1016/0090-6980(87)90038-4. [DOI] [PubMed] [Google Scholar]
  29. Yu S. M., Wu T. S., Teng C. M. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Br J Pharmacol. 1994 Mar;111(3):906–912. doi: 10.1111/j.1476-5381.1994.tb14824.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES